116 related articles for article (PubMed ID: 18852148)
1. Long-term progression and therapeutic response of visceral metastatic disease non-invasively monitored in mouse urine using beta-human choriogonadotropin secreting tumor cell lines.
Francia G; Emmenegger U; Lee CR; Shaked Y; Folkins C; Mossoba M; Medin JA; Man S; Zhu Z; Witte L; Kerbel RS
Mol Cancer Ther; 2008 Oct; 7(10):3452-9. PubMed ID: 18852148
[TBL] [Abstract][Full Text] [Related]
2. Impact of metronomic UFT/cyclophosphamide chemotherapy and antiangiogenic drug assessed in a new preclinical model of locally advanced orthotopic hepatocellular carcinoma.
Tang TC; Man S; Lee CR; Xu P; Kerbel RS
Neoplasia; 2010 Mar; 12(3):264-74. PubMed ID: 20234820
[TBL] [Abstract][Full Text] [Related]
3. Comparative impact of trastuzumab and cyclophosphamide on HER-2-positive human breast cancer xenografts.
Francia G; Man S; Lee CJ; Lee CR; Xu P; Mossoba ME; Emmenegger U; Medin JA; Kerbel RS
Clin Cancer Res; 2009 Oct; 15(20):6358-66. PubMed ID: 19825954
[TBL] [Abstract][Full Text] [Related]
4. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
Kerbel RS
Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
[TBL] [Abstract][Full Text] [Related]
5. The potential clinical promise of 'multimodality' metronomic chemotherapy revealed by preclinical studies of metastatic disease.
Kerbel RS; Shaked Y
Cancer Lett; 2017 Aug; 400():293-304. PubMed ID: 28202353
[TBL] [Abstract][Full Text] [Related]
6. Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis.
Kerbel RS; Guerin E; Francia G; Xu P; Lee CR; Ebos JM; Man S
Breast; 2013 Aug; 22 Suppl 2():S57-65. PubMed ID: 24074794
[TBL] [Abstract][Full Text] [Related]
7. Strategies for delaying or treating in vivo acquired resistance to trastuzumab in human breast cancer xenografts.
du Manoir JM; Francia G; Man S; Mossoba M; Medin JA; Viloria-Petit A; Hicklin DJ; Emmenegger U; Kerbel RS
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):904-16. PubMed ID: 16467105
[TBL] [Abstract][Full Text] [Related]
8. A noninvasive approach for assessing tumor hypoxia in xenografts: developing a urinary marker for hypoxia.
Nelson DW; Cao H; Zhu Y; Sunar-Reeder B; Choi CY; Faix JD; Brown JM; Koong AC; Giaccia AJ; Le QT
Cancer Res; 2005 Jul; 65(14):6151-8. PubMed ID: 16024616
[TBL] [Abstract][Full Text] [Related]
9. [Monitoring impact of measurement of urinary beta-human chorionic gonadotropin on orthotopic implantation model of human ovarian carcinoma in athymic nude mice].
Li J; Xing H; Gao QL; Lu YP; Wang SX; Zhang AL; Xi L; Ma D
Ai Zheng; 2002 Sep; 21(9):949-53. PubMed ID: 12508539
[TBL] [Abstract][Full Text] [Related]
10. HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice.
Iezzi M; Quaglino E; Cappello P; Toto V; Sabatini F; Curcio C; Garotta G; Musiani P; Cavallo F
Int J Immunopathol Pharmacol; 2011; 24(3):621-30. PubMed ID: 21978694
[TBL] [Abstract][Full Text] [Related]
11. Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy.
Munoz R; Man S; Shaked Y; Lee CR; Wong J; Francia G; Kerbel RS
Cancer Res; 2006 Apr; 66(7):3386-91. PubMed ID: 16585158
[TBL] [Abstract][Full Text] [Related]
12. Significant immunohistochemical expression of human chorionic gonadotropin in high-grade osteosarcoma is rare, but may be associated with clinically elevated serum levels.
Lee AF; Pawel BR; Sullivan LM
Pediatr Dev Pathol; 2014; 17(4):278-85. PubMed ID: 24856811
[TBL] [Abstract][Full Text] [Related]
13. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
Man S; Munoz R; Kerbel RS
Cancer Metastasis Rev; 2007 Dec; 26(3-4):737-47. PubMed ID: 17846863
[TBL] [Abstract][Full Text] [Related]
14. Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group.
Wildiers H; Tryfonidis K; Dal Lago L; Vuylsteke P; Curigliano G; Waters S; Brouwers B; Altintas S; Touati N; Cardoso F; Brain E
Lancet Oncol; 2018 Mar; 19(3):323-336. PubMed ID: 29433963
[TBL] [Abstract][Full Text] [Related]
15. β-hCG promotes epithelial ovarian cancer metastasis through ERK/MMP2 signaling pathway.
Wu W; Gao H; Li X; Peng S; Yu J; Liu N; Zhan G; Zhu Y; Wang K; Guo X
Cell Cycle; 2019 Jan; 18(1):46-59. PubMed ID: 30582718
[TBL] [Abstract][Full Text] [Related]
16. B Subunit of Human Chorionic Gonadotropin Promotes Tumor Invasion and Predicts Poor Prognosis of Early-Stage Colorectal Cancer.
Li J; Yin M; Song W; Cui F; Wang W; Wang S; Zhu H
Cell Physiol Biochem; 2018; 45(1):237-249. PubMed ID: 29357321
[TBL] [Abstract][Full Text] [Related]
17. Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer.
Liu N; Peng SM; Zhan GX; Yu J; Wu WM; Gao H; Li XF; Guo XQ
Oncol Rep; 2017 Sep; 38(3):1464-1472. PubMed ID: 28713970
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a spontaneous metastasis tumor model for human ErbB-2 vaccine.
Dai X; He Y; Yao W; Gao X
Biomed Pharmacother; 2017 Apr; 88():991-998. PubMed ID: 28178631
[TBL] [Abstract][Full Text] [Related]
19. Quantifying spontaneous metastasis in a syngeneic mouse melanoma model using real time PCR.
Deng W; McLaughlin SL; Klinke DJ
Analyst; 2017 Aug; 142(16):2945-2953. PubMed ID: 28725894
[TBL] [Abstract][Full Text] [Related]
20. Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer.
Orlando L; Cardillo A; Ghisini R; Rocca A; Balduzzi A; Torrisi R; Peruzzotti G; Goldhirsch A; Pietri E; Colleoni M
BMC Cancer; 2006 Sep; 6():225. PubMed ID: 16978400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
